Article info
PDFCorrespondence
Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?’
- Correspondence to Professor Dafna D Gladman, University of Toronto, Toronto, Ontario, Canada; dafna.gladman{at}utoronto.ca
Citation
Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?’
Publication history
- Received February 10, 2022
- Accepted February 12, 2022
- First published April 29, 2022.
Online issue publication
July 13, 2023
Article Versions
- Previous version (13 July 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.